How Much Did AristaMD Raise?
Funding & Key Investors

AristaMD has secured significant enterprise-level funding, with its total capital raised standing at $57.4M. The company recently announced a major strategic investment of $16.5M, marking a pivotal moment in its growth trajectory. This latest financing round underscores the increasing investor confidence in AristaMD's innovative approach to healthcare access.

What is AristaMD?

AristaMD
SoftwareHealthcare SoftwareHealthcare Services

AristaMD is at the forefront of enhancing patient outcomes by streamlining access to specialized medical care. The company's proprietary eConsult platform functions as a sophisticated telehealth solution, empowering primary care physicians to conduct electronic consultations. This process significantly optimizes the patient referral pathway, ensuring timely and high-quality care. The platform is engineered for seamless integration into existing physician referral workflows, enabling payers and providers to efficiently deploy specialist eConsults. These can utilize either their in-house specialists or AristaMD's own network of board-certified experts. AristaMD's solution has demonstrated its capacity to deliver cost-effective and prompt access to specialty services, substantially reducing the necessity for in-person visits and elevating patient satisfaction. The company actively partners with healthcare stakeholders to facilitate their transition to value-based care models.

How much funding has AristaMD raised?

AristaMD has raised a total of $57.4M across 7 funding rounds:

2014

Debt

$2.1M

2015

Debt

$1.4M

2016

Debt

$1.4M

Series A

$11M

2017

Debt

$1M

2020

Series B

$24M

2023

Series C

$16.5M

Debt (2014): $2.1M with participation from Avalon Ventures, LLC

Debt (2015): $1.4M led by Undisclosed

Debt (2016): $1.4M supported by GoFormz Inc.

Series A (2016): $11M featuring Correlation Ventures and Avalon Ventures

Debt (2017): $1M, investors not publicly disclosed

Series B (2020): $24M with participation from CU Healthcare Innovation Fund, .406 Capital, Ascension Ventures Ltd, Cigna Ventures, Avalon Ventures, Stanford Health Care, and MemorialCare

Series C (2023): $16.5M, investors not publicly disclosed

Key Investors in AristaMD

Avalon Ventures, LLC

Avalon Ventures is a venture capital firm with over 30 years of experience focusing on seed and early-stage companies, particularly in the life sciences and information technology sectors. The firm is driven by a team of former entrepreneurs who are passionate about supporting disruptive ideas in dynamic market environments. Avalon Ventures aims to build strong relationships and achieve significant results for its clients. Their expertise lies in navigating the challenges of company creation and fostering innovation.

Correlation Ventures

Correlation Ventures is focused on reinventing industries through innovative investment strategies. They provide groundbreaking data science to help companies like Synthorx and Personal Capital transform their respective fields. The firm aims to support businesses in making rapid investment decisions, enabling them to achieve lasting value. Their portfolio includes companies that are dedicated to addressing significant challenges, such as food waste reduction by Imperfect Foods.

MemorialCare

Founded in 1907, MemorialCare is a hospital that operates primary hospitals and multiple outpatient facilities and programs. They are located in Long Beach, California.

What's next for AristaMD?

The recent major strategic investment in AristaMD signals a strong validation of its business model and its potential for significant expansion within the digital health sector. This capital infusion is expected to accelerate product development, enhance market penetration, and potentially fuel strategic partnerships or acquisitions. As AristaMD continues to navigate the evolving landscape of value-based care, this funding will be instrumental in scaling its operations and solidifying its position as a leader in telehealth solutions for specialty care access. The company is well-positioned to capitalize on the growing demand for efficient, patient-centric healthcare delivery systems.

See full AristaMD company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Software industry

Enterprise Resource Planning (ERP)SoftwareBusiness Intelligence (BI) Software
Customer Engagement PlatformsSoftware
Engineering SoftwareSoftwareBusiness ServicesSoftware Testing
Security SoftwareSoftware

Frequently Asked Questions Regarding AristaMD Financial Insights

What are the most recent funding rounds that AristaMD has completed, and what were the funding rounds?
AristaMD has recently completed 3 funding rounds: Series C on Nov 14, 2023, Series B on Jul 14, 2020, Debt on Jun 28, 2017.
What is the total amount of funding AristaMD has raised to date?
AristaMD has raised a total of $57.4M in funding to date.
How many funding rounds has AristaMD completed?
AristaMD has completed 3 funding rounds.
How much funding did AristaMD raise in its most recent funding round?
AristaMD raised $16.5M in its most recent funding round.
Which was the largest funding round in AristaMD's history?
The largest funding round in AristaMD's history was $24M.
See more information about AristaMD